160 related articles for article (PubMed ID: 15716798)
1. Fatty liver in the intensive care unit.
Paquot N; Delwaide J
Curr Opin Clin Nutr Metab Care; 2005 Mar; 8(2):183-7. PubMed ID: 15716798
[TBL] [Abstract][Full Text] [Related]
2. Etiopathogenesis of nonalcoholic steatohepatitis.
Chitturi S; Farrell GC
Semin Liver Dis; 2001; 21(1):27-41. PubMed ID: 11296694
[TBL] [Abstract][Full Text] [Related]
3. From fatty liver to fibrosis: a tale of "second hit".
Basaranoglu M; Basaranoglu G; Sentürk H
World J Gastroenterol; 2013 Feb; 19(8):1158-65. PubMed ID: 23483818
[TBL] [Abstract][Full Text] [Related]
4. Non-alcoholic fatty liver disease. From insulin resistance to mitochondrial dysfunction.
Solís Herruzo JA; García Ruiz I; Pérez Carreras M; Muñoz Yagüe MT
Rev Esp Enferm Dig; 2006 Nov; 98(11):844-74. PubMed ID: 17198477
[TBL] [Abstract][Full Text] [Related]
5. [Role of lipid peroxidation in non-alcoholic steatohepatitis].
Fraenkel E; Lazúrová I; Fehér J
Orv Hetil; 2004 Mar; 145(12):611-8. PubMed ID: 15119115
[TBL] [Abstract][Full Text] [Related]
6. Pathogenesis of steatohepatitis.
Day CP
Best Pract Res Clin Gastroenterol; 2002 Oct; 16(5):663-78. PubMed ID: 12406438
[TBL] [Abstract][Full Text] [Related]
7. Drug-induced toxicity on mitochondria and lipid metabolism: mechanistic diversity and deleterious consequences for the liver.
Begriche K; Massart J; Robin MA; Borgne-Sanchez A; Fromenty B
J Hepatol; 2011 Apr; 54(4):773-94. PubMed ID: 21145849
[TBL] [Abstract][Full Text] [Related]
8. Mitochondrial dysfunction in NASH: causes, consequences and possible means to prevent it.
Begriche K; Igoudjil A; Pessayre D; Fromenty B
Mitochondrion; 2006 Feb; 6(1):1-28. PubMed ID: 16406828
[TBL] [Abstract][Full Text] [Related]
9. [Role of oxidative stress in non-alcoholic steatohepatitis].
Mitsuyoshi H; Itoh Y; Okanoue T
Nihon Rinsho; 2006 Jun; 64(6):1077-82. PubMed ID: 16768112
[TBL] [Abstract][Full Text] [Related]
10. Common pathogenic mechanism in development progression of liver injury caused by non-alcoholic or alcoholic steatohepatitis.
Nagata K; Suzuki H; Sakaguchi S
J Toxicol Sci; 2007 Dec; 32(5):453-68. PubMed ID: 18198478
[TBL] [Abstract][Full Text] [Related]
11. Role of mitochondria in non-alcoholic fatty liver disease.
Pessayre D
J Gastroenterol Hepatol; 2007 Jun; 22 Suppl 1():S20-7. PubMed ID: 17567459
[TBL] [Abstract][Full Text] [Related]
12. Non-alcoholic steatohepatitis and metabolic syndrome.
Machado M; Cortez-Pinto H
Curr Opin Clin Nutr Metab Care; 2006 Sep; 9(5):637-42. PubMed ID: 16912563
[TBL] [Abstract][Full Text] [Related]
13. Lipid injectable emulsions: 2006.
Driscoll DF
Nutr Clin Pract; 2006 Aug; 21(4):381-6. PubMed ID: 16870806
[TBL] [Abstract][Full Text] [Related]
14. Insulin resistance and oxidative stress interdependency in non-alcoholic fatty liver disease.
Videla LA; Rodrigo R; Araya J; Poniachik J
Trends Mol Med; 2006 Dec; 12(12):555-8. PubMed ID: 17049925
[TBL] [Abstract][Full Text] [Related]
15. Environmental and genetic determinants of fatty liver in humans.
Kantartzis K; Schick F; Häring HU; Stefan N
Dig Dis; 2010; 28(1):169-78. PubMed ID: 20460907
[TBL] [Abstract][Full Text] [Related]
16. Role of fatty liver, dietary fatty acid supplements, and obesity in the progression of alcoholic liver disease: introduction and summary of the symposium.
Purohit V; Russo D; Coates PM
Alcohol; 2004 Aug; 34(1):3-8. PubMed ID: 15670659
[TBL] [Abstract][Full Text] [Related]
17. Prevention of parenteral nutrition-associated liver disease: role of omega-3 fish oil.
Fallon EM; Le HD; Puder M
Curr Opin Organ Transplant; 2010 Jun; 15(3):334-40. PubMed ID: 20503524
[TBL] [Abstract][Full Text] [Related]
18. Non-alcoholic steatohepatitis: pathogenesis and novel therapeutic approaches.
Schuppan D; Schattenberg JM
J Gastroenterol Hepatol; 2013 Aug; 28 Suppl 1():68-76. PubMed ID: 23855299
[TBL] [Abstract][Full Text] [Related]
19. Mitochondria in steatohepatitis.
Pessayre D; Berson A; Fromenty B; Mansouri A
Semin Liver Dis; 2001; 21(1):57-69. PubMed ID: 11296697
[TBL] [Abstract][Full Text] [Related]
20. [Nonalcoholic steatohepatitis: pathogenesis and treatment].
Park SH
Korean J Hepatol; 2008 Mar; 14(1):12-27. PubMed ID: 18367854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
